Link (paywall): https://www.afr.com/street-talk/anthropic-s-plans-to-buy-1-4gw-of-aussie-data-centre-capacity-20260705-p60cpz

Sarah Thompson, Kanika Sood, Emma Rapaport
Jul 5, 2026

The world’s most valuable artificial intelligence company, Anthropic, wants to buy at least 1.4 gigawatts of capacity from Australian data centres that will cost as much as $US15 billion ($21.6 billion) to build, far exceeding previous estimates of its needs.

A tender issued confidentially by Anthropic, and obtained by Street Talk, shows it is aiming to start using at least 1 gigawatt of this capacity by the end of next year, after opening its Australian office earlier this year.

The documents state the Dario Amodei-led company’s base case was to find a “long-term partner” that could build a large-scale 1.4GW-plus data centre campus. And it is willing to partake in the development risk.

“We recognise that a likely outcome is identification of an optimal development partner without a fully developed site – in that scenario, we envision jointly identifying and developing a site that meets our requirements,” the request-for-proposal stated.

The RFP, which landed in offices of CDC Data Centres, AirTrunk, NextDC, Iren and Stack among other players, culminated in an initial round of proposals at end of March. A handful of parties were invited to on-site meetings in Canberra in early April, when Amodei was in town to meet Treasurer Jim Chalmers.

As of Sunday, Anthropic was said to be at least six weeks away from making a final decision, with expectations it could split the deal into four or five smaller contracts instead of signing up with just one data centre landlord as was its base case.

Should it go down this route, Infratil-owned CDC Centre is expected to come out with the lion’s share at about 500MW, sources said.

An Anthropic spokeswoman declined to comment.

Got receipts?

The tender documents offer a rare glimpse into what Anthropic – which was valued at $US965 billion ($1.4 trillion) in its Series H raising in May, outstripping rival OpenAI’s valuation – expects of its data centre partners. Both companies are working towards initial public offerings.

The RFP laid out an 11-point checklist for Australian data centre bosses to pitch their credentials on.

Top of this list was “financial capabilities”, where Anthropic wanted to know how a data centre landlord – who stands to earn billions in revenue from the deal – would go about securing the $US12 billion to $US15 billion in debt and equity needed for the project. And how this financing would be underwritten, given Anthropic – despite its status as the most valuable AI company – is still “non investment-grade” according to credit agencies.

Next, it wanted the full details on the applicant’s land bank, including if they could house four or more buildings without being in a residential area or in a school’s backyard.

From here, the RFP’s criteria drilled into specifics of the applicant’s track record. Anthropic asked for one-page summaries on every Australian data centre that company has built to date exceeding 200MWs, requesting the fine-print on development and construction timelines, data hall power density and energy details to name a few.

Show me the money

The giant also requested summaries on how an applicant met the energy needs of projects above 300MW. It asked data centres to prioritise providing examples of “on-premises generation or co-development with independent power producers”.

Applicants were asked to submit organisational charts with names of key leaders in design and construction.

“[Also provide] current development pipeline and evidence that your business has sufficient capacity and supply chain relationships to deliver a project of this scale alongside existing commitments,” the document said.

Bidders were told to provide preferred and alternative commercial structures – aka how they shall make money; in particular, Anthropic’s solicited feedback around “pricing lock-in across multiple handovers over a multi-year period”.

Lastly, Anthropic sought assurances around security and government affairs expertise.

The beauty parade, revealed by Street Talk last month, comes after Anthropic cut the ribbon on its Australian operations, promised investment in Australian universities, and powered through Canberra earlier this year. Weeks later, it extended access to its vaunted Mythos model to Australian companies, only for the Trump administration to step in and ban foreign sales of the product.

All these events hit front pages across Australia, but details of Anthropic’s data centre capacity purchase contracts have been kept under wraps so far.

Link: https://www.forbes.com/sites/greatspeculations/2026/07/01/ai-data-center-stock-iren-approaches-a-historically-bullish-setup/

Shares of AI data center giant IREN (IREN) are moving 3.9% lower at $43.94 this afternoon, pulling back as a choppy tech sector weighs on investors. Despite the blockchain specialist’s debut on the Russell 1000 Index (RUT) earlier this week, the equity is headed for an eighth-straight daily drop—its lowest close since April. However, not all is lost. In fact, IREN is sporting a 14.8% year-to-date lead and now looks to be within a chip shot of a historically bullish trendline.

According to Schaeffer’s Senior Quantitative Analyst Rocky White, IREN is trading within 0.75 times the 260-day moving average's 20-day average true range (ATR), after spending at least 80% of the previous two weeks and 80% of the prior 42 trading sessions above that trendline.

This signal has flashed five times over the last decade, after which the stock was higher one month later 60% of the time, averaging a 19.9% gain. A similar move from the stock’s current perch would put the AI powerhouse at $52.68.

Bears look firmly in control, with 18.7% of the stock’s available float sold short. Short interest rose 26.5% during the past two reporting periods, leaving less than two days for sellers to buy back their bearish bets while IREN is ripe for a squeeze.

Options traders have been bearish as well, leaving more room for bulls should this attention begin to unwind. Specifically, at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), IREN stock's 10-day put/call volume ratio of 4.20 ranks in the highest possible percentile of its annual range.

This sub gets flooded with bears who post and comment this kind of slop anytime the stock is red. I don’t mind seeing opposing points of view, but these posts and comments are ruining the community. These people have zero interest in investing in IREN they only come here to troll.

The easiest win I use in other investing subs is to set a community karma requirement. Anyone with negative karma in this sub can’t make new posts or comments. Easiest to set up and instant bang for buck.

A more nuanced approach is to make a rule banning bashing/troll/shortselling posts and comments. Creates more work for you guys but this is the best method with the most flexibility.

🥱

Let the catchup target raises begin… Expecting to see a lot of these in the coming week.

Help me wish the BEST BOY a happy 12th birthday!! We had to celebrate with a legit doggy cake this year 🥳

No real news dropped but love to see my CEO doing the media circuit

Link: https://www.whitehouse.gov/fact-sheets/2026/05/fact-sheet-president-donald-j-trump-secures-historic-deals-with-china-delivering-for-american-workers-farmers-and-industry/

CONTRIBUTING TO PEACE AND PROSPERITY:

This week, during the first visit of a U.S. President to the People’s Republic of China since 2017, President Donald J. Trump reached consensus with President Xi Jinping on several issues that will enhance stability and confidence for businesses and consumers around the world.

President Trump and President Xi agreed that the United States and China should build a constructive relationship of strategic stability on the basis of fairness and reciprocity. President Trump will welcome President Xi for a visit to Washington this fall. The two countries will support each other as the respective hosts of the G20 and APEC Summits later this year. 

Both leaders agreed Iran cannot have a nuclear weapon, called to reopen the Strait of Hormuz, and agreed that no country or organization can be allowed to charge tolls. 
President Trump and President Xi confirmed their shared goal to denuclearize North Korea.

ESTABLISHING U.S.-CHINA BOARDS OF TRADE AND INVESTMENT:

As the cornerstone of this historic agreement, President Trump and President Xi chartered two new institutions to optimize the bilateral economic relationship: the U.S.-China Board of Trade and the U.S.-China Board of Investment. 

The Board of Trade will allow the United States Government and the Government of China to manage bilateral trade across non-sensitive goods.  
The Board of Investment will provide a government-to-government forum for discussing investment-related issues.

DELIVERING FOR AMERICAN WORKERS, FARMERS, AND INDUSTRY:

President Trump negotiated a sweeping package of commitments that will drive high-paying American jobs and open new markets for U.S. goods.

China will address U.S. concerns regarding supply chain shortages related to rare earths and other critical minerals, including yttrium, scandium, neodymium, and indium. China will also address U.S. concerns regarding prohibitions or restrictions on the sale of rare earth production and processing equipment and technologies.

China approved an initial purchase of 200 American-made Boeing aircraft for Chinese airlines. This tranche of aircraft – China’s first commitment to purchase American-made Boeing aircraft since 2017 – will drive high-paying, high-skilled U.S. manufacturing jobs and enable the Chinese people to fly on American-made planes for decades to come. 

China will purchase at least $17 billion per year of U.S. agricultural products in 2026 (prorated), 2027, and 2028, in addition to the soybean purchase commitments that it made in October 2025.

China restored market access for U.S. beef by renewing expired listings of more than 400 U.S. beef facilities and adding new listings.  China will work with U.S. regulators to lift all suspensions of U.S. beef facilities.

China resumed imports of poultry from U.S. states determined by the USDA to be free of highly pathogenic avian influenza.

So far BOT’s fund is highly concentrated (~75%) in 3 companies, Figure AI, Apptronik, and Dyna Robotics. The rest strike me as speculative dart throws that could turn into huge windfalls if they execute.

I’ve broken down each of their top 9 holdings including allocation percentage, a brief description, and their growth plans. These stats are current as of BOT’s Feb 28, 2026 filing with the SEC.

Hopefully you guys find this useful. I put a lot of time into it and helped inform my own investment in Robostrategy.

———

Figure AI — 25.48% of NAV

Founded in 2022 by Brett Adcock, Figure AI develops humanoid robots designed to work in real-world environments. Three generations of robots (Figure 01–03) have been developed, along with two iterations of its VLA model, Helix, which can control up to two robots simultaneously.

Growth Outlook: Near-term catalysts include scaling Figure 03 production toward 12,000 annual unit capacity at its BotQ manufacturing facility, expanding commercial deployments beyond BMW (reportedly adding UPS), and demonstrating Helix AI in increasingly complex real-world environments. The global humanoid robot market is projected by Morgan Stanley to reach $5 trillion by 2050, with over 1 billion robots in operation.

———

Apptronik — 25.47% of NAV

Apptronik is a UT Austin–founded robotics company focused on creating AI-powered robots. Their humanoid, Apollo, is built to work alongside humans in essential industries like manufacturing and logistics, with plans to expand into healthcare and eventually home use. Apollo represents nearly ten years of development built on Apptronik’s experience with 15 previous robots, including NASA’s Valkyrie.

Growth Outlook: The company plans to ramp Apollo production, expand global pilot and commercial deployments, build advanced facilities for robot training and data collection, and debut a new robot version in 2026. It has already signed partnerships with Mercedes-Benz, GXO Logistics, and Jabil, and has a strategic partnership with Google DeepMind to build next-gen humanoids powered by Gemini Robotics.

———

Dyna Robotics — 25.48% of NAV

Founded in 2024 by Lindon Gao, York Yang, and former DeepMind research scientist Jason Ma, Dyna Robotics aims to have robots complete tasks at human-level speed. Unlike peers developing humanoid robots, Dyna focuses on robotic arms powered by its DYNA-1 foundation model. After just six months, Dyna’s robots were running sixteen hours a day at hotels, restaurants, laundromats, and gyms. The company is the first to build a single-weight, general-purpose foundation model that can perform diverse daily tasks at commercial scale across varied environments.

Growth Outlook: Strong near-term commercial traction differentiates Dyna from pure-R&D competitors. Its on-the-job learning loop, where each deployment improves the model, creates compounding advantages as it scales.

———

Dexmate — 6.84% of NAV

Dexmate is a US-based robotics startup founded by PhDs from MIT, UCSD, and Carnegie Mellon. Their flagship product, Vega, is a dual-armed mobile humanoid robot featuring high-payload arms, dexterous hands, and a foldable torso design for compact transport. Its omni-directional base supports over 10 hours of continuous operation, making it suitable for complex tasks in industrial and household environments. Unlike many humanoid robots that rely on bipedal walking, Dexmate’s system uses an omnidirectional wheeled base paired with a humanoid upper body giving it stability advantages in industrial settings.

Growth Outlook: Dexmate received additional funding in February 2026 and has raised $41M total. Its combination of a wheeled base (more reliable than bipedal locomotion for industrial use) with dexterous dual arms positions it as a pragmatic, near-term deployable solution.

———

Path Robotics — 4.10% of NAV

Path Robotics provides robotic welding systems for enhanced precision and adaptability. The company uses AI-powered vision and autonomy to automate one of the most technically demanding industrial tasks, welding, in manufacturing environments where traditional automation has historically struggled.

Growth Outlook: Path Robotics signed an MOU with HII (Huntington Ingalls Industries) for military shipbuilding robotics integration, a high-value government contract pipeline that could significantly accelerate revenue. Defense and heavy manufacturing welding automation is a large addressable market with limited competition.

———

REK, Inc. — 1.71% of NAV

REK operates a live-action humanoid robot combat league. Think “BattleBots meets humanoid AI.” While speculative, this is a high-profile consumer entertainment and R&D testbed concept that could drive public interest and media attention in humanoid robotics broadly. A small but high-optionality bet.

Growth Outlook: Very early stage. Primary value may lie in brand-building for the humanoid robotics sector and in driving data generation from extreme-condition robot operation.

———

GMI Cloud — 1.37% of NAV

GMI Cloud offers a GPU cloud backbone for AI infrastructure. The company unveiled a $12B, 1GW Sovereign AI Infrastructure Initiative in Japan, targeting the growing demand for AI compute capacity in Asia.

Growth Outlook: AI infrastructure is one of the most capital-intensive and competitively in-demand sectors globally. GMI’s sovereign AI angle, building national AI compute capacity, taps into a strong government-driven tailwind, especially in Asia.

———

CoCo Robotics — 1.03% of NAV

CoCo Robotics focuses on autonomous sidewalk delivery for dense urban networks, operating a fleet of last-mile delivery robots in cities. This is a more near-term commercial use case than humanoids, with active deployments already underway.

Growth Outlook: As urban delivery costs rise and labor shortages persist, sidewalk robots represent one of the most economically viable near-term robotics applications. The SAFE structure suggests this is a small early-stage bet on a potential breakout.

———

Endiatx — 0.34% of NAV

Endiatx is a minimally-invasive medical robotics startup, developing pill-sized robotic devices that can navigate the GI tract. Essentially a swallowable robot doctor. This is one of the most differentiated and speculative positions in the portfolio.

Growth Outlook: Medical robotics is a massive long-term market. If Endiatx’s ingestible robotics technology achieves FDA clearance, the addressable market could be enormous but the regulatory timeline is long and uncertain.

I’m starting a new position in BOT Monday to get exposure to Figure and the other early stage humanoid robotics companies.

Kinda scary from a jobs standpoint but major US manufactures are salivating over this kind of tech and it’s advancing FAST alongside AI.

I’ll make another post outlining all of BOT’s fund allocations and briefly describe each one. What an exciting space to invest in.